Table 7 Treatment of HER+ patient cohort (TMAs 226 and 227).

From: Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

Treatment

# pts in TMAs 226 and 227 (n = 189)

# pts in ITH cohort (n = 77)

Chemotherapy

33

18

Hormone therapy

25

6

Chemotherapy + hormone therapy

85

33

Chemotherapy + trastuzumab

6

4

Chemo + hormone + trastuzumab

12

6

n/a

28

10

Back to article page